ICU Medical, Inc. (ICUI) Tops Q1 EPS by 10c; Raises FY11 EPS Outlook
ICU Medical, Inc. (NASDAQ: ICUI) reported Q1 EPS of $0.57, $0.10 better than the analyst estimate of $0.47. Revenue for the quarter came in at $71.5 million versus the consensus estimate of $70.4 million.
Raises its FY11 EPS guidance from $2.25-$2.45 to $2.30-$2.50, which compares to the Street estimate of $2.38. The company maintains its FY11 sales guidance of $295-$305 million, vs. the consensus of $305.8 million.
Raises its FY11 EPS guidance from $2.25-$2.45 to $2.30-$2.50, which compares to the Street estimate of $2.38. The company maintains its FY11 sales guidance of $295-$305 million, vs. the consensus of $305.8 million.